3 ms·
What makes you assume that the SV assumption is that other companies are stupid or lazy? Siemens doesn't have to be a bunch of idiots to not pursue devices tha
by icebraining 8y ago
What makes you assume that the SV assumption is that other companies are stupid or lazy?
Siemens doesn't have to be a bunch of idiots to not pursue devices that test on smaller amounts of blood; they might simply not have an incentive to do so. If their business model is to sell devices to labs for $$$$, reducing the amount of blood is probably not a big selling point. It only becomes so if you're trying to bypass the lab and go more directly to the customer (as in Theranos with Walgreens). But why would Siemens do that, when it's a less profitable product that directly competes with the other?
For all we know, Siemens already has a smaller, cheaper device that uses only a drop of blood, yet no reason to sell it until they get some competition.
- projektfu 8y agoIn the veterinary market we use analyzers that require ~100uL blood, about two drops of an eyedropper. Device makers have machines that run the gamut from tiny and portable to room sized, and the main difference is throughput. My analyzer can run about 3 samples per hour. A big Siemens or Toshiba can be continuously loaded to run hundreds. The biggest risk from a medical standpoint of using a machine like Theranos wanted was using capillary blood. You really would need a lot of data to interpret the results like we have for venous blood.
- chopin 8y ago> For all we know, Siemens already has a smaller, cheaper device that uses only a drop of blood, yet no reason to sell it until they get some competition. Do you have a source for this? As far as I remember past discussions on HN about Theranos, testing on small samples is notoriously difficult. As an experimental physicist, this seems plausible to me: Say 5% error margin on your result is required. This leaves a lot more leeway for dimensional errors (of the sampling chamber) compared to a few µl. Not to speak of introducing external impurities (or those induced by the sampling as mentioned by the article). I am pretty sure Siemens has lots of incentive to err on the safe side. If we really like to disrupt this industry, it would be nicer to be able to make these tests in-vivo, in my opinion.
- deleted 8y ago[deleted]
- adwn 8y ago> Do you have a source for this? In case you're not a native English speaker: "for all we know" means something like "hypothetically". icebraining's point is that Siemens' behavior is not inconsistent with Siemens having a secret device that can reliably test on small samples, even if they don't sell it. icebraining did not mean to imply that Siemens actually has such a device.